Transbronchial Needle Forceps for Endobronchial Ultrasound

Transbronchial Needle Forceps for EBUS

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01145924

Enrollment

Registered

2010-06-17

Start date

2010-01-31

Completion date

2010-08-31

Last updated

2010-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Lymph Nodes

Keywords

bronchoscopy, endobronchial ultrasound, transbronchial needle aspiration, lung cancer, staging

Brief summary

Prove the feasibility of a needle forceps in patients with enlarged mediastinal lymph nodes

Detailed description

Patients with enlarged mediastinal lymph nodes must be staged. The EBUS TBNA technique is an established technique. Unfortunately the size of the needle is limited to 21 gauge. With tne new designed needle forceps it should be possible to obtain more material and establish the diagnosis more often

Interventions

PROCEDUREEBUS TBNF

Transbronchial needle forceps will be use with the EBUS TBNA scope

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* enlarged mediastinal lymph nodes

Exclusion criteria

* comorbidities

Design outcomes

Primary

Measure	Time frame
Number of Participants with a positive biopsy result	2 days after intervention

Secondary

Measure	Time frame
Number of Participants with Adverse Events as a Measure of Safety and Tolerability	3 weeks after

Countries

Germany

Contacts

Primary ContactFelix JF Herth, PhD, MD

Felix.Herth@thoraxklinik-heidelberg.de+49 6221 396

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026